Management of bleeding gastric varices
Authors:
- Ambreen A. SonawallaASAmbreen A. Sonawalla
- Sana F. SomaniSSSana F. Somani
- Shahab AbidSAShahab Abid
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 26 (6) , 661-667
Abstract
Gastric variceal bleeding is one of the most feared complications of portal hypertension and hence merits investigation for its optimal therapy. We aimed to evaluate the efficacy and long-term outcome(s) of patients treated with a single session of histoacryl sclerotherapy for active gastric variceal bleeding. The medical records of patients who presented with active gastric variceal bleeding between 1998 and 2011 in a tertiary care setting were evaluated retrospectively and the eventual outcome(s) (initial hemostasis, rebleeding, and mortality rate) was assessed at least 1 year after the index bleed. Ninety-seven patients were included. The mean age of the patients was 51.0 ± 12.5 years; 62% were men. Hepatitis C was the most common etiology, found in 63 (65%) patients. The majority of the patients were classified as Child-Pugh grade B and C: 44 (46%) and 29 (31%) patients, respectively. A total of 40 (41%) patients were IGV1, 35 (36%) patients were GOV 2, 20 (21%) patients were GOV 1, and 2 (2%) patients were IGV2. A single session of histoacryl was successful in controlling bleeding in 83 (86%) patients. Seven (7%) patients died during the hospital stay. Rebleeding was observed in 24 (27%) patients during the 1-year follow-up, of whom 12 (50%) were managed successfully with repeated histoacryl injection. The overall mortality rate at 6 weeks, 6 months, and 1 year was 14 (14%), 19 (20%) and 26 (27%) patients, respectively. Child-Pugh classification was a significant prognostic factor of survival (P<0.001). A single session of histoacryl sclerotherapy is effective in the majority of patients with active gastric variceal bleeding. Rebleeding was observed in one-fourth of patients, half of whom were controlled successfully by repeated histoacryl sclerotherapy.Keywords
This publication has 22 references indexed in Scilit:
- Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2010
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology, 2007
- Enbucrilate for gastric varices: extended experience in 92 patientsAlimentary Pharmacology & Therapeutics, 2007
- Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleedingWorld Journal of Gastroenterology, 2007
- A randomized trial of endoscopic treatment of acute gastric variceal hemorrhageHepatology, 2006
- Transjugular intrahepatic portosystemic shunt: current status1 1Abbreviation used in this paper: TIPS, transjugular intrahepatic portosystemic shunt.Gastroenterology, 2003
- A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varicesAmerican Journal of Gastroenterology, 2002
- NATURAL HISTORY OF PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSISClinics in Liver Disease, 2001
- A Prospective, Randomized Trial of Butyl Cyanoacrylate Injection Versus Band Ligation in the Management of Bleeding Gastric VaricesHepatology, 2001
- Ethanolamine Oleate Versus Butyl Cyanoacrylate for Bleeding Gastric Varices: a Nonrandomized StudyEndoscopy, 1995